Advertisement

The Scientist

» business

Most Recent

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

image: Celladon Shutters Its R&D

Celladon Shutters Its R&D

By | June 26, 2015

Biotech firm likely to pull the plug after its gene therapy product fails.

0 Comments

image: Another CAR-T IPO

Another CAR-T IPO

By | April 6, 2015

Cellectis goes public for a whopping $228 million—nearly double the value the company filed for in February.

0 Comments

image: Roche Snags Tumor Tester for $1B

Roche Snags Tumor Tester for $1B

By | January 13, 2015

The pharmaceutical company bought a majority stake in Foundation Medicine, a firm that develops personalized cancer-medicine diagnostics.

0 Comments

image: SAIC Founder Dies

SAIC Founder Dies

By | December 30, 2014

J. Robert Beyster, who established one of the largest research and engineering firms, passed away at age 90.

0 Comments

image: Merck Buys Sigma-Aldrich for $17B

Merck Buys Sigma-Aldrich for $17B

By | September 22, 2014

Two giants merge as the German drug maker acquires the US-based science supply company.

1 Comment

image: Keeping Up with IP

Keeping Up with IP

By | September 1, 2014

It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.

0 Comments

image: Roche Buys Biotech for $8.3B

Roche Buys Biotech for $8.3B

By | August 27, 2014

The pharma giant strikes a deal to acquire InterMune, a Brisbane, California-based biotech with only one product—a treatment for a fatal lung disease.

0 Comments

image: Biotech Terminates IPO

Biotech Terminates IPO

By | August 15, 2014

The Israeli firm Vascular Biogenics withdrew its initial public offering after six days of trading. 

0 Comments

image: Scripps’s President Steps Down

Scripps’s President Steps Down

By | July 23, 2014

Following widespread disapproval among faculty members, Scripps’s Michael Marletta resigns his post.

1 Comment

Advertisement

Popular Now

  1. Most Earth-like Planet Found
  2. AAAAA Is for Arrested Translation
  3. Antibiotic Resistance Can Boost Bacterial Fitness
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Advertisement
The Scientist